KMT2A and thymus gland adenocarcinoma: Among other molecular alterations the thymic adenocarcinoma harbored a mutation in KMT2A c.2155A > C(p.S719R), while the type A thymoma harbored a different KMT2A mutation c.5343del(p.V178Yfs*38).